- Report
- January 2022
- 181 Pages
Global
From €4047EUR$4,450USD£3,467GBP
- Report
- October 2021
- 293 Pages
Global
From €4047EUR$4,450USD£3,467GBP
- Report
- July 2021
- 151 Pages
Europe
From €3137EUR$3,450USD£2,688GBP
- Report
- July 2026
United Kingdom
From €3629EUR$3,990USD£3,109GBP
From €3629EUR$3,990USD£3,109GBP
- Report
- July 2026
United Kingdom
From €3629EUR$3,990USD£3,109GBP
From €3629EUR$3,990USD£3,109GBP
- Report
- July 2026
United Kingdom
From €3629EUR$3,990USD£3,109GBP
- Report
- August 2025
- 39 Pages
Africa, Middle East
From €455EUR$500USD£390GBP
- Report
- August 2025
- 43 Pages
North America
From €455EUR$500USD£390GBP
- Report
- August 2025
- 42 Pages
Europe
From €455EUR$500USD£390GBP
- Report
- August 2025
- 42 Pages
Asia Pacific
From €455EUR$500USD£390GBP
- Report
- August 2025
- 46 Pages
Global
From €455EUR$500USD£390GBP
- Clinical Trials
- June 2025
- 281 Pages
Global
From €3137EUR$3,450USD£2,688GBP
- Clinical Trials
- June 2025
Global
From €3137EUR$3,450USD£2,688GBP
- Clinical Trials
- June 2025
Global
From €3137EUR$3,450USD£2,688GBP
- Report
- June 2025
- 15 Pages
Global
From €16365EUR$17,995USD£14,021GBP
- Report
- June 2025
- 106 Pages
Global
From €16365EUR$17,995USD£14,021GBP
- Report
- June 2025
- 112 Pages
Global
From €16365EUR$17,995USD£14,021GBP
- Report
- June 2025
- 101 Pages
Global
From €16365EUR$17,995USD£14,021GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more